Ashland Inc. income statement
In fiscal 2025, Ashland Inc. reported revenue of $1.82bn, down 13.7% on the year before, operating income of −$775m (a -42.5% margin) and net income of −$845m, or −$18.23 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,100 | 3,420 | 3,019 | 2,309 | 2,589 | 2,148 | 2,016 | 2,111 | 2,391 | 2,191 | 2,113 | 1,824 | 1,842 |
| Cost of revenue | 4,605 | 2,532 | 2,132 | 1,580 | 1,726 | 1,497 | 1,417 | 1,441 | 1,561 | 1,523 | 1,495 | 1,275 | 1,261 |
| Gross profit | 1,516 | 888 | 887 | 729 | 863 | 651 | 599 | 670 | 830 | 668 | 618 | 549 | 581 |
| Research and development | 114 | 99 | 87 | 73 | 73 | 58 | 56 | 50 | 55 | 51 | 55 | 54 | 55 |
| Selling, general and administrative | 1,358 | 692 | 858 | 610 | 599 | 426 | 400 | 358 | 393 | 365 | 404 | 344 | 340 |
| Operating income | 46 | 112 | −50 | 49 | 102 | 86 | −461 | 192 | 333 | 172 | −26 | −775 | 137 |
| Interest expense | −163 | −166 | 180 | 227 | 116 | 114 | 88 | 69 | 62 | 54 | 53 | 61 | — |
| Net interest income | −166 | −174 | −173 | −229 | −102 | −99 | −119 | −56 | −149 | −6 | 24 | −33 | −17 |
| Income before tax | −116 | −151 | −308 | −196 | 11 | −9 | −577 | 135 | 206 | 160 | −24 | −809 | 126 |
| Income tax | −188 | −139 | −25 | −16 | −8 | 30 | −22 | −38 | 25 | −8 | −223 | 13 | 51 |
| Net income | 233 | 309 | −29 | 1 | 114 | 505 | −508 | 220 | 927 | 178 | 169 | −845 | 52 |
| Diluted EPS | $3.00 | $4.54 | −$0.47 | $0.01 | $1.79 | $8.15 | −$8.39 | $3.59 | $16.41 | $3.31 | $3.36 | −$18.23 | — |
| Diluted shares (average) | 78m | 68m | 63m | 62m | 64m | 62m | 61m | 61m | 56m | 54m | 50m | 46m | — |
| EBITDA | 439 | 418 | 252 | 314 | 379 | 363 | −226 | 436 | 574 | 415 | 248 | −538 | 297 |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 522 | 405 | 479 | 463 | 477 | 386 | 482 | 497 |
| Cost of revenue | 348 | 294 | 332 | 331 | 318 | 281 | 335 | 327 |
| Gross profit | 174 | 111 | 147 | 132 | 159 | 105 | 147 | 170 |
| Research and development | 13 | 13 | 14 | 13 | 13 | 13 | 14 | 15 |
| Selling, general and administrative | 101 | 78 | 85 | 106 | 76 | 86 | 79 | 99 |
| Operating income | 31 | −179 | 51 | −708 | 61 | −6 | 39 | 43 |
| Net interest income | 10 | −28 | −11 | 5 | 1 | −8 | −18 | 8 |
| Income before tax | 25 | −209 | 39 | −704 | 65 | −15 | 20 | 56 |
| Income tax | 6 | −43 | 9 | 15 | 32 | −1 | 5 | 15 |
| Net income | 16 | −165 | 31 | −742 | 32 | −12 | 16 | 16 |
| Diluted EPS | $0.35 | −$3.50 | $0.65 | −$16.21 | $0.62 | −$0.26 | $0.34 | $0.35 |
| EBITDA | 84 | −128 | 96 | −647 | 111 | 42 | 69 | 75 |
Compare with peers
- Innospec Inc. income statement
- Sensient Technologies Corp income statement
- Quaker Chemical Corp income statement
- Minerals Technologies Inc income statement
- Stepan Co income statement
Head to head: ASH vs IOSPASH vs SXTASH vs KWR
More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies